ANDAORALTABLET
Lifecycle
Pre-Launch
Data completeness
2/8 — Basic
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE (linagliptin and metformin hydrochloride) by PharmaIN is dipeptidyl peptidase 4 inhibitors [moa]. Approved for dipeptidyl peptidase 4 inhibitor [epc].
Drug data last refreshed 1mo ago
Mechanism of Action
Dipeptidyl Peptidase 4 Inhibitors
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
PharmaIN
WA - Bothell
Worked on LINAGLIPTIN AND METFORMIN HYDROCHLORIDE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.